Treace Medical Concepts TMCI
NASDAQ TMCI
$4.46 -0.10 (-2.19%)
As of: Aug 20, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026)

Treace Medical Concepts' (TMCI) quarterly Total Non-Current Liabilities came in at $103.9 million in Q1 2026, up 3.38% YoY from $100.5 million in Q1 2025, and up 0.72% on a QoQ basis from $103.1 million in Q4 2025.

Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Treace Medical Concepts (TMCI) has 7 years of Total Non-Current Liabilities data on file, last reported at $103.9 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 3.38% year-over-year to $103.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.9 million (up 3.38% YoY) and the FY2025 annual result came in at $103.1 million, down 1.01% from the prior year.
  • Total Non-Current Liabilities rose to $103.9 million in Q1 2026, from $103.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $116.3 million in Q1 2024 to a low of $59.6 million in Q1 2022.
  • A 5-year average of $100.7 million and a median of $103.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 135.5% — and 2025, when it retreated 13.61%.
  • Tracing TMCI's Total Non-Current Liabilities over 5 years: stood at $98.5 million in 2022, then increased by 15.66% to $113.9 million in 2023, then decreased by 8.56% to $104.2 million in 2024, then slipped by 1.01% to $103.1 million in 2025, then rose by 0.72% to $103.9 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $103.9 million (Q1 2026), $103.1 million (Q4 2025), and $107.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 Treace Medical Concepts 290.12 Mn 244.50 Mn 35.61 Mn 110.63 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 110.63 Mn
Mar 31, 2026 103.86 Mn
Dec 31, 2025 103.12 Mn
Sep 30, 2025 107.21 Mn
Jun 30, 2025 108.67 Mn
Mar 31, 2025 100.47 Mn
Dec 31, 2024 104.17 Mn
Sep 30, 2024 107.98 Mn
Jun 30, 2024 113.82 Mn
Mar 31, 2024 116.30 Mn
Dec 31, 2023 113.92 Mn
Sep 30, 2023 102.46 Mn
Jun 30, 2023 99.65 Mn
Mar 31, 2023 91.53 Mn
Dec 31, 2022 98.50 Mn
Sep 30, 2022 94.24 Mn
Jun 30, 2022 87.01 Mn
Mar 31, 2022 59.61 Mn
Dec 31, 2021 47.58 Mn
Sep 30, 2021 40.02 Mn